QC
CLVS

QCM Cayman’s Clovis Oncology, Inc. CLVS Stock Holding History

QCM Cayman’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-10,512
Closed -$41K – 52
2019
Q3 		$41K Buy
+10,512
New +$85K 0.59% 32
2018
Q1 		– Sell
-3,672
Closed -$250K – 198
2017
Q4 		$250K Buy
+3,672
New +$257K 1.04% 36
2015
Q4 		– Sell
-6,599
Closed -$607K – 276
2015
Q3 		$607K Buy
+6,599
New +$571K 0.2% 48

Other funds holding CLVS

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

QCM Cayman's CLVS Position: Q4 2019 in Review

QCM Cayman sold out of Clovis Oncology, Inc. (CLVS) in Q4 2019, closing a stake of 10,512 shares — an estimated $41K sold.

QCM Cayman first reported a position in CLVS in Q3 2015 and held it in 3 quarters. The position peaked at $607K in Q3 2015. 147 funds tracked by Wall St. Rank hold CLVS as of Q4 2019.

  • QCM Cayman reported no remaining Clovis Oncology, Inc. position as of Q4 2019 after selling out during the quarter.
  • QCM Cayman sold 10,512 Clovis Oncology, Inc. shares in Q4 2019, an estimated $41K.
  • QCM Cayman first reported a position in Clovis Oncology, Inc. in Q3 2015 and held it in 3 quarters.
  • QCM Cayman's Clovis Oncology, Inc. position peaked at $607K in Q3 2015.
  • 147 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2019.

Based on QCM Cayman's 13F filing for Q4 2019, filed 14 Feb 2020.